A phase II evaluation of nivolumab, a fully human antibody against PD-1, in the treatment of persistent or recurrent cervical cancer Meeting Abstract
| Authors: | Santin, A.; Deng, W.; Frumovitz, M. M.; Huh, W. K.; Khleif, S.; Lankes, H. A.; Ratner, E.; O'Cearbhaill, R.; Jazaeri, A. A.; Birrer, M. |
| Abstract Title: | A phase II evaluation of nivolumab, a fully human antibody against PD-1, in the treatment of persistent or recurrent cervical cancer |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 302s |
| Language: | English |
| ACCESSION: | WOS:000442916002231 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.5536 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5536 -- Source: Wos |
